Showing results (11-20 of 82) with videos related to
Sort By:
Pageof 9
European Journal of Pharmacology|June 5, 2003
Effects of a selective agonist and antagonist of CRF2 receptors on cardiovascular function in the ratKenneth B Mackay, Theodore H Stiefel, Nick Ling, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 17, 2004
Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult ratsRamanjit Gill, John A Kemp, Caroline Sabin, et al.Experimental Brain Research|May 3, 2005
Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditionsManuela De Michele, Omar Touzani, Alan C Foster, et al.Neuropharmacology|September 6, 2002
Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- miceJames N C Kew, Marie-Claire Pflimlin, John A Kemp, et al.Plos One|November 1, 2019
BDNF, NT-3 and Trk receptor agonist monoclonal antibodies promote neuron survival, neurite extension, and synapse restoration in rat cochlea ex vivo models relevant for hidden hearing lossStephanie Szobota, Pranav D Mathur, Sairey Siegel, et al.Psychopharmacology|March 11, 2005
Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the ratGuy A Higgins, Theresa M Ballard, Michel Enderlin, et al.Journal of Medicinal Chemistry|July 23, 2004
Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonistsChen Chen, Jinghua Yu, Beth A Fleck, et al.The Journal of Pharmacology and Experimental Therapeutics|September 2, 2018
Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual DysfunctionYong-Xin Li, Jia-Ying Yang, Miguel Alcantara, et al.Neurogenetics|March 31, 2006
Gene expression analyses reveal molecular relationships among 20 regions of the human CNSRichard B Roth, Peter Hevezi, Jerry Lee, et al.Molecular Pharmacology|September 2, 2021
Therapeutic Neuroprotection by an Engineered Neurotrophin that Selectively Activates Tropomyosin Receptor Kinase (Trk) Family Neurotrophin Receptors but Not the p75 Neurotrophin ReceptorFouad Brahimi, Alba Galan, Sairey Siegel, et al.Pageof 9